By regulating the abundance of intestinal flora to activate FUNDC1-mediated mitochondrial autophagy and inhibit NLRP3-mediated inflammation, we can adjust the homeostasis of intracellular environment and treat renal disease. This evidence concerns the gene NLRP3 and kidney disorder.